The Global Initiative for Asthma released its updated global strategy for asthma prevention and management earlier this year. As-needed combination low-dose ICS-formoterol is recommended as first-line treatment over short-acting beta2-agonists alone for adults and adolescents aged 12 years and older.
The incidence of drug-induced interstitial lung disease is likely to increase in the future with advances in drug development. The cornerstone of management is early detection and cessation of the inciting medication.
Frailty often occurs concurrently with chronic lung disease. However, due to overlapping risk factors, the impact of frailty is overlooked, particularly in younger patients with chronic lung disease. Maintaining vigilance for frailty indicators and co-ordinated multidisciplinary input can enhance early detection and management.
In May 2023, policy changes were introduced to tackle the growing use of electronic cigarettes and their associated harms. These changes pose some novel challenges for GPs, as they play a pivotal role in addressing this public health issue.
Physician-authored summaries and
commentary on the most important
medical research, provided by the
NEJM Group, a division of the
Massachusetts Medical Society.